Add BrightSurf on Google Email

Venn diagram tactics to vet complex disease

A study using Venn diagram tactics categorizes mutation types in cells from different patients, identifying a novel cause of lethal neonatal mitochondrial complex I deficiency. The authors demonstrate the technique's strength by pinpointing mutations in the NDUFS6 gene, a previously unknown contributor to this disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 15, 2004

Stroke and sensory rehabilitation research

Researchers investigate auditory brainstem responses for early detection of ototoxic hearing loss, as well as sensory rehabilitation methods such as obstacle avoidance training, blind rehabilitation, and constraint-induced therapy. These studies aim to minimize or prevent debilitating hearing loss and improve mobility function in indiv...

SourceVeterans Affairs Research Communications·JournalThe Journal of Rehabilitation Research and Development·DateJul 8, 2004

Message to moms

Research suggests that when mothers use a controlling approach, children become disengaged and perform poorly in school. In contrast, an autonomy-supportive approach improves children's performance immediately and leads to better grades over time. The study emphasizes the importance of this parenting style for low-achieving children.

SourceSociety for Research in Child Development·JournalChild Development·DateMay 14, 2004

Who wants to talk about premature ejaculation?

A scientific working group found that renaming premature ejaculation could lead to confusion and require re-education. Instead, they recommend using the current term to describe the condition, which is associated with stigma rather than the name itself. The group also emphasizes the importance of open dialogue about male sexual health.

The future of drug development

Researchers Hubbard and Love propose a new system for funding drug development, separating R&D and product markets. This could lead to greater openness in drug research, reduced prices, and expanded access to new medicines.

SourcePLOS·JournalPLOS Biology·DateFeb 17, 2004